Details for Patent: 10,881,617
✉ Email this page to a colleague
Which drugs does patent 10,881,617 protect, and when does it expire?
Patent 10,881,617 protects PYRIDOSTIGMINE BROMIDE and is included in one NDA.
This patent has nineteen patent family members in seven countries.
Drugs Protected by US Patent 10,881,617
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET, EXTENDED RELEASE;ORAL | 217604-001 | Oct 4, 2024 | DISCN | No | No | 10,881,617 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,881,617
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3031412 | ⤷ Subscribe | |||
| Canada | 3061382 | ⤷ Subscribe | |||
| China | 110996922 | ⤷ Subscribe | |||
| Denmark | 3609472 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
